Literature DB >> 12049555

Randomized controlled trials for evaluating surgical questions.

Eric K Fung1, John M Loré.   

Abstract

OBJECTIVE: To discuss some of the obstacles inherent in the design of the randomized controlled trial (RCT) that the surgeon must confront and options to minimize these obstacles. DATA SOURCES: The literature was searched for articles discussing RCTs using MEDLINE from 1966 to 1998. STUDY SELECTION: Studies relevant to the general use of RCTs for evaluating surgical questions were selected. SYNTHESIS: Several problems inherent in RCTs were noted: (1) ethical considerations, (2) difficulties in patient accrual, (3) patient preferences, and (4) variability in surgical proficiency/technique. Some means of minimizing these problems are (1) the concept of clinical equipoise, (2) multicenter trials, and (3) stratified sampling of patients. Alternatives to the classic RCT are discussed, namely, the randomized consent design and the patient preference design.
CONCLUSIONS: The nature of the RCTs is that they are difficult to use to evaluate surgical techniques. Some options are available to minimize these difficulties. Designing and conducting RCTs to evaluate surgical interventions require careful planning and some compromises. Unless the previously mentioned criteria are applied, the validity of the RCT can be considered no greater than that of other trials.

Entities:  

Mesh:

Year:  2002        PMID: 12049555     DOI: 10.1001/archotol.128.6.631

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  11 in total

Review 1.  Clinical research methodology I: introduction to randomized trials.

Authors:  Lillian S Kao; Jon E Tyson; Martin L Blakely; Kevin P Lally
Journal:  J Am Coll Surg       Date:  2008-02       Impact factor: 6.113

2.  Surgical interventions for uterine prolapse and for vault prolapse: the two VUE RCTs.

Authors:  Christine Hemming; Lynda Constable; Beatriz Goulao; Mary Kilonzo; Dwayne Boyers; Andrew Elders; Kevin Cooper; Anthony Smith; Robert Freeman; Suzanne Breeman; Alison McDonald; Suzanne Hagen; Isobel Montgomery; John Norrie; Cathryn Glazener
Journal:  Health Technol Assess       Date:  2020-03       Impact factor: 4.014

3.  Wound morbidity in mini-invasive thyroidectomy.

Authors:  Gianlorenzo Dionigi; Luigi Boni; Francesca Rovera; Stefano Rausei; Renzo Dionigi
Journal:  Surg Endosc       Date:  2010-06-05       Impact factor: 4.584

4.  Unruptured Intracranial Aneurysms. Opinions of Experts in Endovascular Treatment Are Coherent,Weighted in Favour of Treatment, and Incompatible with ISUIA.

Authors:  J Raymond; T Nguyen; M Chagnon; G Gevry
Journal:  Interv Neuroradiol       Date:  2007-09-15       Impact factor: 1.610

5.  Surgical Considerations to Improve Recovery in Acute Spinal Cord Injury.

Authors:  Troy Q Tabarestani; Nicholle E Lewis; Margot Kelly-Hedrick; Nina Zhang; Brianna R Cellini; Eric J Marrotte; Theresa Williamson; Haichen Wang; Daniel T Laskowitz; Timothy D Faw; Muhammad M Abd-El-Barr
Journal:  Neurospine       Date:  2022-09-30

6.  Why don't women participate? A qualitative study on non-participation in a surgical randomised controlled trial.

Authors:  D Gopinath; A R B Smith; C Holland; F M Reid
Journal:  Int Urogynecol J       Date:  2012-11-01       Impact factor: 2.894

Review 7.  Adaption and application of the four phase trials to traditional chinese medicines.

Authors:  M Y Di; J L Tang
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-20       Impact factor: 2.629

8.  Primary outcome in a randomized controlled trial: a critical issue.

Authors:  Deepti Choudhary; Pankaj K Garg
Journal:  Saudi J Gastroenterol       Date:  2011 Sep-Oct       Impact factor: 2.485

9.  Class or level of evidence: epidemiologic basis.

Authors:  Joseph Dettori
Journal:  Evid Based Spine Care J       Date:  2012-08

10.  Biopsy vs. extensive resection for first recurrence of glioblastoma: is a prospective clinical trial warranted?

Authors:  Christopher Dardis; Lynn Ashby; William Shapiro; Nader Sanai
Journal:  BMC Res Notes       Date:  2015-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.